The present disclosure encompasses methods (hereinafter termed `Microarray-based Genomic Selection` (MGS), capable of isolating user-defined unique genomic sequences from complex eukaryotic genomes.

 
Web www.patentalert.com

< USE OF AT LEAST ONE CYTOSOLIC PHOSPHOLIPASE A2 INHIBITOR AS A MEDICINE FOR SYMPTOMATIC TREATMENT OF MUCOVISCIDOSIS

> Inhibitor Nucleic Acids

> NUCLEIC ACID ENCODING RECEPTOR TYPE PROTEIN KINASE
~ 00597